LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 15 of 15: Calculated dose-response metrics. - Dataset (ID:20252)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | GR_AOC |
|---|---|---|
| MDA-MB-231 | KIN001-043 | 0.2179 |
| MDA-MB-231 | Lapatinib | 0.0923 |
| MDA-MB-231 | LDN-193189 | 0.4025 |
| MDA-MB-231 | Linifanib | 0.0133 |
| MDA-MB-231 | Linsitinib | 0.1616 |
| MDA-MB-231 | Mitoxantrone | 1.1989 |
| MDA-MB-231 | MK2206 | 0.1967 |
| MDA-MB-231 | Neratinib | 0.3586 |
| MDA-MB-231 | Nilotinib | 0.2092 |
| MDA-MB-231 | Nintedanib | 0.0919 |
| MDA-MB-231 | NU7441 | 0.2227 |
| MDA-MB-231 | NVP-AEW541 | 0.0977 |
| MDA-MB-231 | Luminespib | 1.0891 |
| MDA-MB-231 | NVP-TAE684 | 0.5395 |
| MDA-MB-231 | OSI-027 | 0.2659 |
| MDA-MB-231 | Palbociclib | 0.5401 |
| MDA-MB-231 | PD0325901 | 0.8037 |
| MDA-MB-231 | PD173074 | 0.0359 |
| MDA-MB-231 | PD184352 | 0.3263 |
| MDA-MB-231 | Pelitinib | 0.3096 |
| MDA-MB-231 | PF431396 | 0.6090 |
| MDA-MB-231 | PF477736 | 0.3984 |
| MDA-MB-231 | PF562271 | 0.4651 |
| MDA-MB-231 | PHA-665752 | 0.1371 |
| MDA-MB-231 | PHA-793887 | 0.9797 |